nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP3A4—Temozolomide—melanoma	0.19	0.385	CbGbCtD
Oxymorphone—CYP2D6—Vemurafenib—melanoma	0.164	0.332	CbGbCtD
Oxymorphone—CYP3A4—Vemurafenib—melanoma	0.104	0.211	CbGbCtD
Oxymorphone—CYP3A4—Docetaxel—melanoma	0.0357	0.0724	CbGbCtD
Oxymorphone—Cancer pain—Docetaxel—melanoma	0.0257	0.0829	CcSEcCtD
Oxymorphone—Intracranial pressure increased—Carmustine—melanoma	0.00689	0.0223	CcSEcCtD
Oxymorphone—Altered state of consciousness—Temozolomide—melanoma	0.00602	0.0195	CcSEcCtD
Oxymorphone—Naloxone—TLR4—melanoma	0.00564	0.614	CrCbGaD
Oxymorphone—Lung disorder—Temozolomide—melanoma	0.00393	0.0127	CcSEcCtD
Oxymorphone—Memory impairment—Temozolomide—melanoma	0.00354	0.0114	CcSEcCtD
Oxymorphone—Drug interaction—Carmustine—melanoma	0.0031	0.01	CcSEcCtD
Oxymorphone—Weight decreased—Vemurafenib—melanoma	0.00309	0.00998	CcSEcCtD
Oxymorphone—Injection site reaction—Carmustine—melanoma	0.00286	0.00924	CcSEcCtD
Oxymorphone—Depressed level of consciousness—Carmustine—melanoma	0.00278	0.00898	CcSEcCtD
Oxymorphone—Depressed level of consciousness—Temozolomide—melanoma	0.00269	0.00867	CcSEcCtD
Oxymorphone—Disorientation—Bleomycin—melanoma	0.00268	0.00864	CcSEcCtD
Oxymorphone—Ileus—Docetaxel—melanoma	0.00261	0.00844	CcSEcCtD
Oxymorphone—Eye disorder—Vemurafenib—melanoma	0.00255	0.00825	CcSEcCtD
Oxymorphone—Cardiac disorder—Vemurafenib—melanoma	0.00254	0.00819	CcSEcCtD
Oxymorphone—Dermatitis atopic—Docetaxel—melanoma	0.0025	0.00807	CcSEcCtD
Oxymorphone—Mental disability—Carmustine—melanoma	0.0025	0.00807	CcSEcCtD
Oxymorphone—Angiopathy—Vemurafenib—melanoma	0.00248	0.00801	CcSEcCtD
Oxymorphone—Mediastinal disorder—Vemurafenib—melanoma	0.00246	0.00795	CcSEcCtD
Oxymorphone—Mental disability—Temozolomide—melanoma	0.00241	0.00779	CcSEcCtD
Oxymorphone—Malnutrition—Vemurafenib—melanoma	0.00238	0.00768	CcSEcCtD
Oxymorphone—Lethargy—Dactinomycin—melanoma	0.00228	0.00736	CcSEcCtD
Oxymorphone—Amnesia—Carmustine—melanoma	0.00222	0.00718	CcSEcCtD
Oxymorphone—Hot flush—Temozolomide—melanoma	0.00216	0.00697	CcSEcCtD
Oxymorphone—Amnesia—Temozolomide—melanoma	0.00215	0.00694	CcSEcCtD
Oxymorphone—Menopausal symptoms—Temozolomide—melanoma	0.00214	0.00691	CcSEcCtD
Oxymorphone—Diplopia—Carmustine—melanoma	0.00209	0.00675	CcSEcCtD
Oxymorphone—Bronchospasm—Bleomycin—melanoma	0.00203	0.00657	CcSEcCtD
Oxymorphone—Diplopia—Temozolomide—melanoma	0.00202	0.00652	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00201	0.0065	CcSEcCtD
Oxymorphone—Oliguria—Docetaxel—melanoma	0.00201	0.00648	CcSEcCtD
Oxymorphone—Drug interaction—Docetaxel—melanoma	0.00199	0.00644	CcSEcCtD
Oxymorphone—Nervous system disorder—Vemurafenib—melanoma	0.0019	0.00615	CcSEcCtD
Oxymorphone—Skin disorder—Vemurafenib—melanoma	0.00189	0.00609	CcSEcCtD
Oxymorphone—Dehydration—Temozolomide—melanoma	0.00188	0.00606	CcSEcCtD
Oxymorphone—Weight decreased—Bleomycin—melanoma	0.00187	0.00604	CcSEcCtD
Oxymorphone—Pneumonia—Bleomycin—melanoma	0.00186	0.00599	CcSEcCtD
Oxymorphone—Injection site reaction—Docetaxel—melanoma	0.00184	0.00594	CcSEcCtD
Oxymorphone—Hypotension—Vemurafenib—melanoma	0.00181	0.00586	CcSEcCtD
Oxymorphone—Abdominal distension—Temozolomide—melanoma	0.00176	0.00567	CcSEcCtD
Oxymorphone—Pneumonia—Dactinomycin—melanoma	0.00173	0.00559	CcSEcCtD
Oxymorphone—Sweating increased—Temozolomide—melanoma	0.0017	0.00549	CcSEcCtD
Oxymorphone—Decreased appetite—Vemurafenib—melanoma	0.00169	0.00545	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Vemurafenib—melanoma	0.00168	0.00541	CcSEcCtD
Oxymorphone—Fatigue—Vemurafenib—melanoma	0.00167	0.00541	CcSEcCtD
Oxymorphone—Constipation—Vemurafenib—melanoma	0.00166	0.00536	CcSEcCtD
Oxymorphone—Pneumonia—Carmustine—melanoma	0.00162	0.00523	CcSEcCtD
Oxymorphone—Weight decreased—Temozolomide—melanoma	0.00158	0.0051	CcSEcCtD
Oxymorphone—Pneumonia—Temozolomide—melanoma	0.00156	0.00505	CcSEcCtD
Oxymorphone—Flushing—Bleomycin—melanoma	0.00154	0.00496	CcSEcCtD
Oxymorphone—Body temperature increased—Vemurafenib—melanoma	0.00153	0.00496	CcSEcCtD
Oxymorphone—Hallucination—Carmustine—melanoma	0.00144	0.00464	CcSEcCtD
Oxymorphone—Hot flush—Docetaxel—melanoma	0.00144	0.00464	CcSEcCtD
Oxymorphone—Flushing—Dactinomycin—melanoma	0.00143	0.00463	CcSEcCtD
Oxymorphone—Hypersensitivity—Vemurafenib—melanoma	0.00143	0.00462	CcSEcCtD
Oxymorphone—Menopausal symptoms—Docetaxel—melanoma	0.00142	0.0046	CcSEcCtD
Oxymorphone—Visual disturbance—Docetaxel—melanoma	0.00142	0.00458	CcSEcCtD
Oxymorphone—Asthenia—Vemurafenib—melanoma	0.00139	0.0045	CcSEcCtD
Oxymorphone—Visual impairment—Carmustine—melanoma	0.00139	0.0045	CcSEcCtD
Oxymorphone—Hallucination—Temozolomide—melanoma	0.00139	0.00449	CcSEcCtD
Oxymorphone—Urinary tract disorder—Temozolomide—melanoma	0.00138	0.00445	CcSEcCtD
Oxymorphone—Pruritus—Vemurafenib—melanoma	0.00137	0.00444	CcSEcCtD
Oxymorphone—Lethargy—Docetaxel—melanoma	0.00137	0.00442	CcSEcCtD
Oxymorphone—Urethral disorder—Temozolomide—melanoma	0.00137	0.00442	CcSEcCtD
Oxymorphone—Eye disorder—Carmustine—melanoma	0.00135	0.00436	CcSEcCtD
Oxymorphone—Visual impairment—Temozolomide—melanoma	0.00135	0.00435	CcSEcCtD
Oxymorphone—Flushing—Carmustine—melanoma	0.00134	0.00433	CcSEcCtD
Oxymorphone—Diarrhoea—Vemurafenib—melanoma	0.00133	0.00429	CcSEcCtD
Oxymorphone—Eye disorder—Temozolomide—melanoma	0.00131	0.00422	CcSEcCtD
Oxymorphone—Flushing—Temozolomide—melanoma	0.0013	0.00419	CcSEcCtD
Oxymorphone—Cardiac disorder—Temozolomide—melanoma	0.0013	0.00419	CcSEcCtD
Oxymorphone—Dizziness—Vemurafenib—melanoma	0.00128	0.00415	CcSEcCtD
Oxymorphone—Angiopathy—Temozolomide—melanoma	0.00127	0.00409	CcSEcCtD
Oxymorphone—Mental disorder—Carmustine—melanoma	0.00127	0.00409	CcSEcCtD
Oxymorphone—Immune system disorder—Temozolomide—melanoma	0.00126	0.00407	CcSEcCtD
Oxymorphone—Mediastinal disorder—Temozolomide—melanoma	0.00126	0.00407	CcSEcCtD
Oxymorphone—Malnutrition—Carmustine—melanoma	0.00126	0.00406	CcSEcCtD
Oxymorphone—Dehydration—Docetaxel—melanoma	0.00125	0.00403	CcSEcCtD
Oxymorphone—Vomiting—Vemurafenib—melanoma	0.00123	0.00399	CcSEcCtD
Oxymorphone—Chest pain—Bleomycin—melanoma	0.00123	0.00396	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Docetaxel—melanoma	0.00123	0.00396	CcSEcCtD
Oxymorphone—Mental disorder—Temozolomide—melanoma	0.00122	0.00395	CcSEcCtD
Oxymorphone—Dermatitis—Vemurafenib—melanoma	0.00122	0.00395	CcSEcCtD
Oxymorphone—Headache—Vemurafenib—melanoma	0.00122	0.00393	CcSEcCtD
Oxymorphone—Malnutrition—Temozolomide—melanoma	0.00122	0.00393	CcSEcCtD
Oxymorphone—Confusional state—Bleomycin—melanoma	0.00119	0.00383	CcSEcCtD
Oxymorphone—Vision blurred—Carmustine—melanoma	0.00119	0.00383	CcSEcCtD
Oxymorphone—Oedema—Bleomycin—melanoma	0.00118	0.0038	CcSEcCtD
Oxymorphone—Agitation—Carmustine—melanoma	0.00116	0.00373	CcSEcCtD
Oxymorphone—Nausea—Vemurafenib—melanoma	0.00115	0.00372	CcSEcCtD
Oxymorphone—Vision blurred—Temozolomide—melanoma	0.00115	0.0037	CcSEcCtD
Oxymorphone—Bronchospasm—Docetaxel—melanoma	0.00114	0.00369	CcSEcCtD
Oxymorphone—Anorexia—Bleomycin—melanoma	0.00112	0.00362	CcSEcCtD
Oxymorphone—Agitation—Temozolomide—melanoma	0.00112	0.00361	CcSEcCtD
Oxymorphone—Hypotension—Bleomycin—melanoma	0.0011	0.00355	CcSEcCtD
Oxymorphone—Oedema—Dactinomycin—melanoma	0.0011	0.00354	CcSEcCtD
Oxymorphone—Vertigo—Temozolomide—melanoma	0.00109	0.00353	CcSEcCtD
Oxymorphone—Convulsion—Carmustine—melanoma	0.00109	0.00352	CcSEcCtD
Oxymorphone—Hypertension—Carmustine—melanoma	0.00109	0.00351	CcSEcCtD
Oxymorphone—Palpitations—Temozolomide—melanoma	0.00107	0.00347	CcSEcCtD
Oxymorphone—Chest pain—Carmustine—melanoma	0.00107	0.00346	CcSEcCtD
Oxymorphone—Anxiety—Carmustine—melanoma	0.00107	0.00345	CcSEcCtD
Oxymorphone—Convulsion—Temozolomide—melanoma	0.00105	0.0034	CcSEcCtD
Oxymorphone—Weight decreased—Docetaxel—melanoma	0.00105	0.00339	CcSEcCtD
Oxymorphone—Hypertension—Temozolomide—melanoma	0.00105	0.00339	CcSEcCtD
Oxymorphone—Dyspnoea—Bleomycin—melanoma	0.00105	0.00339	CcSEcCtD
Oxymorphone—Anorexia—Dactinomycin—melanoma	0.00105	0.00338	CcSEcCtD
Oxymorphone—Pneumonia—Docetaxel—melanoma	0.00104	0.00336	CcSEcCtD
Oxymorphone—Confusional state—Carmustine—melanoma	0.00104	0.00334	CcSEcCtD
Oxymorphone—Anxiety—Temozolomide—melanoma	0.00103	0.00333	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00103	0.00332	CcSEcCtD
Oxymorphone—Oedema—Carmustine—melanoma	0.00103	0.00332	CcSEcCtD
Oxymorphone—Decreased appetite—Bleomycin—melanoma	0.00102	0.0033	CcSEcCtD
Oxymorphone—Dry mouth—Temozolomide—melanoma	0.00101	0.00327	CcSEcCtD
Oxymorphone—Pain—Bleomycin—melanoma	0.00101	0.00325	CcSEcCtD
Oxymorphone—Tachycardia—Carmustine—melanoma	0.001	0.00324	CcSEcCtD
Oxymorphone—Confusional state—Temozolomide—melanoma	0.001	0.00323	CcSEcCtD
Oxymorphone—Oedema—Temozolomide—melanoma	0.000992	0.0032	CcSEcCtD
Oxymorphone—Anorexia—Carmustine—melanoma	0.000979	0.00316	CcSEcCtD
Oxymorphone—Nervous system disorder—Temozolomide—melanoma	0.000973	0.00314	CcSEcCtD
Oxymorphone—Feeling abnormal—Bleomycin—melanoma	0.000969	0.00313	CcSEcCtD
Oxymorphone—Skin disorder—Temozolomide—melanoma	0.000964	0.00311	CcSEcCtD
Oxymorphone—Hypotension—Carmustine—melanoma	0.00096	0.0031	CcSEcCtD
Oxymorphone—Hyperhidrosis—Temozolomide—melanoma	0.000959	0.0031	CcSEcCtD
Oxymorphone—Decreased appetite—Dactinomycin—melanoma	0.000954	0.00308	CcSEcCtD
Oxymorphone—Fatigue—Dactinomycin—melanoma	0.000946	0.00305	CcSEcCtD
Oxymorphone—Anorexia—Temozolomide—melanoma	0.000946	0.00305	CcSEcCtD
Oxymorphone—Pain—Dactinomycin—melanoma	0.000938	0.00303	CcSEcCtD
Oxymorphone—Urticaria—Bleomycin—melanoma	0.000935	0.00302	CcSEcCtD
Oxymorphone—Body temperature increased—Bleomycin—melanoma	0.00093	0.003	CcSEcCtD
Oxymorphone—Insomnia—Carmustine—melanoma	0.000929	0.003	CcSEcCtD
Oxymorphone—Naltrexone—ABCB1—melanoma	0.000921	0.1	CrCbGaD
Oxymorphone—Urinary tract disorder—Docetaxel—melanoma	0.000917	0.00296	CcSEcCtD
Oxymorphone—Dyspnoea—Carmustine—melanoma	0.000915	0.00296	CcSEcCtD
Oxymorphone—Somnolence—Carmustine—melanoma	0.000913	0.00295	CcSEcCtD
Oxymorphone—Urethral disorder—Docetaxel—melanoma	0.000911	0.00294	CcSEcCtD
Oxymorphone—Feeling abnormal—Dactinomycin—melanoma	0.000904	0.00292	CcSEcCtD
Oxymorphone—Insomnia—Temozolomide—melanoma	0.000898	0.0029	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Dactinomycin—melanoma	0.000897	0.0029	CcSEcCtD
Oxymorphone—Visual impairment—Docetaxel—melanoma	0.000895	0.00289	CcSEcCtD
Oxymorphone—Decreased appetite—Carmustine—melanoma	0.000893	0.00288	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Carmustine—melanoma	0.000887	0.00286	CcSEcCtD
Oxymorphone—Dyspnoea—Temozolomide—melanoma	0.000885	0.00286	CcSEcCtD
Oxymorphone—Somnolence—Temozolomide—melanoma	0.000882	0.00285	CcSEcCtD
Oxymorphone—Pain—Carmustine—melanoma	0.000878	0.00284	CcSEcCtD
Oxymorphone—Constipation—Carmustine—melanoma	0.000878	0.00284	CcSEcCtD
Oxymorphone—Dyspepsia—Temozolomide—melanoma	0.000873	0.00282	CcSEcCtD
Oxymorphone—Eye disorder—Docetaxel—melanoma	0.000868	0.0028	CcSEcCtD
Oxymorphone—Abdominal pain—Dactinomycin—melanoma	0.000867	0.0028	CcSEcCtD
Oxymorphone—Body temperature increased—Dactinomycin—melanoma	0.000867	0.0028	CcSEcCtD
Oxymorphone—Hypersensitivity—Bleomycin—melanoma	0.000867	0.0028	CcSEcCtD
Oxymorphone—Decreased appetite—Temozolomide—melanoma	0.000863	0.00279	CcSEcCtD
Oxymorphone—Cardiac disorder—Docetaxel—melanoma	0.000862	0.00278	CcSEcCtD
Oxymorphone—Flushing—Docetaxel—melanoma	0.000862	0.00278	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Temozolomide—melanoma	0.000857	0.00277	CcSEcCtD
Oxymorphone—Fatigue—Temozolomide—melanoma	0.000856	0.00276	CcSEcCtD
Oxymorphone—Pain—Temozolomide—melanoma	0.000849	0.00274	CcSEcCtD
Oxymorphone—Constipation—Temozolomide—melanoma	0.000849	0.00274	CcSEcCtD
Oxymorphone—Feeling abnormal—Carmustine—melanoma	0.000846	0.00273	CcSEcCtD
Oxymorphone—Asthenia—Bleomycin—melanoma	0.000844	0.00273	CcSEcCtD
Oxymorphone—Angiopathy—Docetaxel—melanoma	0.000843	0.00272	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Carmustine—melanoma	0.00084	0.00271	CcSEcCtD
Oxymorphone—Immune system disorder—Docetaxel—melanoma	0.000839	0.00271	CcSEcCtD
Oxymorphone—Mediastinal disorder—Docetaxel—melanoma	0.000837	0.0027	CcSEcCtD
Oxymorphone—Pruritus—Bleomycin—melanoma	0.000832	0.00269	CcSEcCtD
Oxymorphone—Feeling abnormal—Temozolomide—melanoma	0.000818	0.00264	CcSEcCtD
Oxymorphone—Mental disorder—Docetaxel—melanoma	0.000814	0.00263	CcSEcCtD
Oxymorphone—Abdominal pain—Carmustine—melanoma	0.000812	0.00262	CcSEcCtD
Oxymorphone—Body temperature increased—Carmustine—melanoma	0.000812	0.00262	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Temozolomide—melanoma	0.000811	0.00262	CcSEcCtD
Oxymorphone—Malnutrition—Docetaxel—melanoma	0.000809	0.00261	CcSEcCtD
Oxymorphone—Hypersensitivity—Dactinomycin—melanoma	0.000808	0.00261	CcSEcCtD
Oxymorphone—Urticaria—Temozolomide—melanoma	0.000788	0.00255	CcSEcCtD
Oxymorphone—Asthenia—Dactinomycin—melanoma	0.000787	0.00254	CcSEcCtD
Oxymorphone—Abdominal pain—Temozolomide—melanoma	0.000784	0.00253	CcSEcCtD
Oxymorphone—Body temperature increased—Temozolomide—melanoma	0.000784	0.00253	CcSEcCtD
Oxymorphone—Hypersensitivity—Carmustine—melanoma	0.000757	0.00244	CcSEcCtD
Oxymorphone—Diarrhoea—Dactinomycin—melanoma	0.000751	0.00242	CcSEcCtD
Oxymorphone—Vomiting—Bleomycin—melanoma	0.000748	0.00242	CcSEcCtD
Oxymorphone—Dermatitis—Bleomycin—melanoma	0.000741	0.00239	CcSEcCtD
Oxymorphone—Asthenia—Carmustine—melanoma	0.000737	0.00238	CcSEcCtD
Oxymorphone—Hypersensitivity—Temozolomide—melanoma	0.000731	0.00236	CcSEcCtD
Oxymorphone—Syncope—Docetaxel—melanoma	0.000725	0.00234	CcSEcCtD
Oxymorphone—Palpitations—Docetaxel—melanoma	0.000715	0.00231	CcSEcCtD
Oxymorphone—Asthenia—Temozolomide—melanoma	0.000712	0.0023	CcSEcCtD
Oxymorphone—Loss of consciousness—Docetaxel—melanoma	0.000711	0.0023	CcSEcCtD
Oxymorphone—Naloxone—ALB—melanoma	0.000704	0.0767	CrCbGaD
Oxymorphone—Diarrhoea—Carmustine—melanoma	0.000703	0.00227	CcSEcCtD
Oxymorphone—Pruritus—Temozolomide—melanoma	0.000702	0.00227	CcSEcCtD
Oxymorphone—Convulsion—Docetaxel—melanoma	0.000701	0.00226	CcSEcCtD
Oxymorphone—Nausea—Bleomycin—melanoma	0.000699	0.00226	CcSEcCtD
Oxymorphone—Hypertension—Docetaxel—melanoma	0.000698	0.00225	CcSEcCtD
Oxymorphone—Vomiting—Dactinomycin—melanoma	0.000698	0.00225	CcSEcCtD
Oxymorphone—Chest pain—Docetaxel—melanoma	0.000688	0.00222	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000684	0.00221	CcSEcCtD
Oxymorphone—Dizziness—Carmustine—melanoma	0.000679	0.00219	CcSEcCtD
Oxymorphone—Diarrhoea—Temozolomide—melanoma	0.000679	0.00219	CcSEcCtD
Oxymorphone—Buprenorphine—ABCB1—melanoma	0.000677	0.0737	CrCbGaD
Oxymorphone—Dry mouth—Docetaxel—melanoma	0.000673	0.00217	CcSEcCtD
Oxymorphone—Naloxone—ABCB1—melanoma	0.000672	0.0732	CrCbGaD
Oxymorphone—Confusional state—Docetaxel—melanoma	0.000665	0.00215	CcSEcCtD
Oxymorphone—Oedema—Docetaxel—melanoma	0.00066	0.00213	CcSEcCtD
Oxymorphone—Dizziness—Temozolomide—melanoma	0.000656	0.00212	CcSEcCtD
Oxymorphone—Vomiting—Carmustine—melanoma	0.000653	0.00211	CcSEcCtD
Oxymorphone—Nausea—Dactinomycin—melanoma	0.000652	0.0021	CcSEcCtD
Oxymorphone—Shock—Docetaxel—melanoma	0.000649	0.0021	CcSEcCtD
Oxymorphone—Nervous system disorder—Docetaxel—melanoma	0.000647	0.00209	CcSEcCtD
Oxymorphone—Dermatitis—Carmustine—melanoma	0.000647	0.00209	CcSEcCtD
Oxymorphone—Tachycardia—Docetaxel—melanoma	0.000644	0.00208	CcSEcCtD
Oxymorphone—Headache—Carmustine—melanoma	0.000643	0.00208	CcSEcCtD
Oxymorphone—Skin disorder—Docetaxel—melanoma	0.000641	0.00207	CcSEcCtD
Oxymorphone—Vomiting—Temozolomide—melanoma	0.000631	0.00204	CcSEcCtD
Oxymorphone—Anorexia—Docetaxel—melanoma	0.000629	0.00203	CcSEcCtD
Oxymorphone—Dermatitis—Temozolomide—melanoma	0.000625	0.00202	CcSEcCtD
Oxymorphone—Headache—Temozolomide—melanoma	0.000622	0.00201	CcSEcCtD
Oxymorphone—Hypotension—Docetaxel—melanoma	0.000617	0.00199	CcSEcCtD
Oxymorphone—Nausea—Carmustine—melanoma	0.00061	0.00197	CcSEcCtD
Oxymorphone—Insomnia—Docetaxel—melanoma	0.000597	0.00193	CcSEcCtD
Oxymorphone—Nausea—Temozolomide—melanoma	0.000589	0.0019	CcSEcCtD
Oxymorphone—Dyspnoea—Docetaxel—melanoma	0.000588	0.0019	CcSEcCtD
Oxymorphone—Somnolence—Docetaxel—melanoma	0.000587	0.00189	CcSEcCtD
Oxymorphone—Dyspepsia—Docetaxel—melanoma	0.000581	0.00188	CcSEcCtD
Oxymorphone—Decreased appetite—Docetaxel—melanoma	0.000574	0.00185	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Docetaxel—melanoma	0.00057	0.00184	CcSEcCtD
Oxymorphone—Fatigue—Docetaxel—melanoma	0.000569	0.00184	CcSEcCtD
Oxymorphone—Morphine—ABCB1—melanoma	0.000567	0.0618	CrCbGaD
Oxymorphone—Constipation—Docetaxel—melanoma	0.000564	0.00182	CcSEcCtD
Oxymorphone—Pain—Docetaxel—melanoma	0.000564	0.00182	CcSEcCtD
Oxymorphone—Feeling abnormal—Docetaxel—melanoma	0.000544	0.00176	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Docetaxel—melanoma	0.00054	0.00174	CcSEcCtD
Oxymorphone—Abdominal pain—Docetaxel—melanoma	0.000522	0.00168	CcSEcCtD
Oxymorphone—Body temperature increased—Docetaxel—melanoma	0.000522	0.00168	CcSEcCtD
Oxymorphone—Hypersensitivity—Docetaxel—melanoma	0.000486	0.00157	CcSEcCtD
Oxymorphone—Asthenia—Docetaxel—melanoma	0.000473	0.00153	CcSEcCtD
Oxymorphone—Pruritus—Docetaxel—melanoma	0.000467	0.00151	CcSEcCtD
Oxymorphone—Diarrhoea—Docetaxel—melanoma	0.000452	0.00146	CcSEcCtD
Oxymorphone—Dizziness—Docetaxel—melanoma	0.000436	0.00141	CcSEcCtD
Oxymorphone—Vomiting—Docetaxel—melanoma	0.00042	0.00136	CcSEcCtD
Oxymorphone—Dermatitis—Docetaxel—melanoma	0.000416	0.00134	CcSEcCtD
Oxymorphone—Headache—Docetaxel—melanoma	0.000413	0.00134	CcSEcCtD
Oxymorphone—Nausea—Docetaxel—melanoma	0.000392	0.00127	CcSEcCtD
Oxymorphone—OPRM1—Signaling Pathways—AKT3—melanoma	5.06e-05	0.00027	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EDN1—melanoma	5.03e-05	0.000268	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL2—melanoma	5.02e-05	0.000268	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TERT—melanoma	5e-05	0.000267	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—RAC1—melanoma	4.99e-05	0.000266	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CSF2—melanoma	4.92e-05	0.000262	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—FGF1—melanoma	4.92e-05	0.000262	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—IL2—melanoma	4.85e-05	0.000259	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—E2F1—melanoma	4.81e-05	0.000257	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CB—melanoma	4.79e-05	0.000256	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HIF1A—melanoma	4.78e-05	0.000255	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PDGFRA—melanoma	4.76e-05	0.000254	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ITGB3—melanoma	4.72e-05	0.000252	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PRKCA—melanoma	4.72e-05	0.000252	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SOCS1—melanoma	4.69e-05	0.00025	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—MAP2K1—melanoma	4.68e-05	0.00025	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—S100B—melanoma	4.68e-05	0.000249	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CD—melanoma	4.65e-05	0.000248	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—SPP1—melanoma	4.62e-05	0.000247	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAP2K2—melanoma	4.61e-05	0.000246	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—CXCL8—melanoma	4.6e-05	0.000246	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KDR—melanoma	4.57e-05	0.000244	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PLCB4—melanoma	4.57e-05	0.000244	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ERBB4—melanoma	4.47e-05	0.000239	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CB—melanoma	4.46e-05	0.000238	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CDKN2B—melanoma	4.43e-05	0.000236	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—FN1—melanoma	4.4e-05	0.000235	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL2—melanoma	4.4e-05	0.000235	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TERT—melanoma	4.38e-05	0.000234	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—RAC1—melanoma	4.37e-05	0.000233	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PLA2G6—melanoma	4.36e-05	0.000233	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NOTCH1—melanoma	4.31e-05	0.00023	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC6A11—melanoma	4.29e-05	0.000229	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIP4K2A—melanoma	4.29e-05	0.000229	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CD86—melanoma	4.29e-05	0.000229	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—CXCL8—melanoma	4.29e-05	0.000229	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EDN1—melanoma	4.25e-05	0.000227	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CD80—melanoma	4.22e-05	0.000225	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KIT—melanoma	4.21e-05	0.000225	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CG—melanoma	4.21e-05	0.000225	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—APC—melanoma	4.21e-05	0.000225	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—NRAS—melanoma	4.21e-05	0.000225	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HIF1A—melanoma	4.19e-05	0.000224	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—MTAP—melanoma	4.18e-05	0.000223	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EGF—melanoma	4.16e-05	0.000222	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FGF1—melanoma	4.16e-05	0.000222	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CSF2—melanoma	4.16e-05	0.000222	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—IL2—melanoma	4.1e-05	0.000218	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—E2F1—melanoma	4.07e-05	0.000217	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CB—melanoma	4.05e-05	0.000216	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—MAPK3—melanoma	4.03e-05	0.000215	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PDGFRA—melanoma	4.03e-05	0.000215	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KDR—melanoma	4.01e-05	0.000214	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ITGB3—melanoma	3.99e-05	0.000213	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PRKCA—melanoma	3.99e-05	0.000213	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—BRAF—melanoma	3.96e-05	0.000211	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—VCAN—melanoma	3.92e-05	0.000209	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—SPP1—melanoma	3.91e-05	0.000209	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAP2K2—melanoma	3.9e-05	0.000208	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—CXCL8—melanoma	3.89e-05	0.000208	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—FN1—melanoma	3.86e-05	0.000206	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IGF1—melanoma	3.86e-05	0.000206	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—MAPK1—melanoma	3.84e-05	0.000205	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—EGFR—melanoma	3.84e-05	0.000205	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NOTCH1—melanoma	3.78e-05	0.000202	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAP2K1—melanoma	3.73e-05	0.000199	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PHGDH—melanoma	3.72e-05	0.000199	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—LUM—melanoma	3.72e-05	0.000199	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL2—melanoma	3.72e-05	0.000198	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TERT—melanoma	3.71e-05	0.000198	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CD—melanoma	3.7e-05	0.000198	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CD80—melanoma	3.7e-05	0.000197	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—RAC1—melanoma	3.7e-05	0.000197	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—APC—melanoma	3.69e-05	0.000197	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KIT—melanoma	3.69e-05	0.000197	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CG—melanoma	3.69e-05	0.000197	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—NRAS—melanoma	3.69e-05	0.000197	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—PIK3CA—melanoma	3.67e-05	0.000196	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EGF—melanoma	3.65e-05	0.000195	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—HPSE—melanoma	3.65e-05	0.000195	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—KRAS—melanoma	3.63e-05	0.000193	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CUBN—melanoma	3.58e-05	0.000191	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—FGF2—melanoma	3.55e-05	0.000189	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HIF1A—melanoma	3.54e-05	0.000189	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—MAPK3—melanoma	3.54e-05	0.000189	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—BRAF—melanoma	3.47e-05	0.000185	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SDHD—melanoma	3.46e-05	0.000185	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CSPG4—melanoma	3.46e-05	0.000185	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—BSG—melanoma	3.46e-05	0.000185	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KDR—melanoma	3.39e-05	0.000181	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IGF1—melanoma	3.38e-05	0.00018	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—MAPK1—melanoma	3.37e-05	0.00018	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—EGFR—melanoma	3.37e-05	0.00018	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GPAM—melanoma	3.35e-05	0.000179	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—PIK3CA—melanoma	3.33e-05	0.000178	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MDM2—melanoma	3.32e-05	0.000177	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP17A1—melanoma	3.3e-05	0.000176	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—ERBB2—melanoma	3.27e-05	0.000175	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAP2K1—melanoma	3.27e-05	0.000174	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FN1—melanoma	3.26e-05	0.000174	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CD—melanoma	3.25e-05	0.000173	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CB—melanoma	3.23e-05	0.000172	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—PIK3CA—melanoma	3.22e-05	0.000172	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NOTCH1—melanoma	3.19e-05	0.00017	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—KRAS—melanoma	3.18e-05	0.00017	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CD80—melanoma	3.13e-05	0.000167	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—APC—melanoma	3.12e-05	0.000167	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KIT—melanoma	3.12e-05	0.000167	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CG—melanoma	3.12e-05	0.000167	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—NRAS—melanoma	3.12e-05	0.000167	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GNA11—melanoma	3.12e-05	0.000166	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—FGF2—melanoma	3.11e-05	0.000166	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CXCL8—melanoma	3.1e-05	0.000165	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EGF—melanoma	3.09e-05	0.000165	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—HRAS—melanoma	3.08e-05	0.000164	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—FASN—melanoma	3.05e-05	0.000163	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CDKN1B—melanoma	3.03e-05	0.000162	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—SLC5A5—melanoma	3e-05	0.00016	CbGpPWpGaD
Oxymorphone—OPRD1—GPCR downstream signaling—AKT1—melanoma	3e-05	0.00016	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—MAPK3—melanoma	2.99e-05	0.00016	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CASP3—melanoma	2.97e-05	0.000158	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL2—melanoma	2.96e-05	0.000158	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—IL6—melanoma	2.95e-05	0.000157	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—BRAF—melanoma	2.93e-05	0.000157	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—PIK3CA—melanoma	2.92e-05	0.000156	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MDM2—melanoma	2.91e-05	0.000155	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—GNAQ—melanoma	2.9e-05	0.000155	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CD44—melanoma	2.9e-05	0.000155	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CCND1—melanoma	2.89e-05	0.000154	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—ERBB2—melanoma	2.87e-05	0.000153	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CTNNB1—melanoma	2.86e-05	0.000153	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IGF1—melanoma	2.86e-05	0.000152	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PLA2G6—melanoma	2.85e-05	0.000152	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—MAPK1—melanoma	2.84e-05	0.000152	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—EGFR—melanoma	2.84e-05	0.000152	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CB—melanoma	2.83e-05	0.000151	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MMP9—melanoma	2.81e-05	0.00015	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—CDKN1A—melanoma	2.8e-05	0.000149	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PTEN—melanoma	2.79e-05	0.000149	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—CYP1B1—melanoma	2.78e-05	0.000148	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NFKB1—melanoma	2.78e-05	0.000148	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAP2K1—melanoma	2.76e-05	0.000147	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CD—melanoma	2.74e-05	0.000146	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling by GPCR—AKT1—melanoma	2.72e-05	0.000145	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CXCL8—melanoma	2.72e-05	0.000145	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—PIK3CA—melanoma	2.72e-05	0.000145	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—HRAS—melanoma	2.7e-05	0.000144	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—KRAS—melanoma	2.69e-05	0.000143	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CDKN1B—melanoma	2.66e-05	0.000142	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—FGF2—melanoma	2.63e-05	0.00014	CbGpPWpGaD
Oxymorphone—OPRK1—GPCR downstream signaling—AKT1—melanoma	2.63e-05	0.00014	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CASP3—melanoma	2.6e-05	0.000139	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL2—melanoma	2.6e-05	0.000139	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—IL6—melanoma	2.59e-05	0.000138	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—VCAN—melanoma	2.56e-05	0.000137	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CCND1—melanoma	2.53e-05	0.000135	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—VEGFA—melanoma	2.52e-05	0.000134	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CTNNB1—melanoma	2.51e-05	0.000134	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—STAT3—melanoma	2.49e-05	0.000133	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—NRAS—melanoma	2.49e-05	0.000133	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—PIK3CA—melanoma	2.47e-05	0.000132	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MMP9—melanoma	2.46e-05	0.000131	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MDM2—melanoma	2.46e-05	0.000131	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—CDKN1A—melanoma	2.45e-05	0.000131	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PTEN—melanoma	2.45e-05	0.00013	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NFKB1—melanoma	2.43e-05	0.00013	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—ERBB2—melanoma	2.42e-05	0.000129	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CB—melanoma	2.39e-05	0.000128	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling by GPCR—AKT1—melanoma	2.39e-05	0.000127	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK3—melanoma	2.38e-05	0.000127	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MYC—melanoma	2.32e-05	0.000124	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CXCL8—melanoma	2.3e-05	0.000123	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ABCB1—melanoma	2.29e-05	0.000122	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—HRAS—melanoma	2.28e-05	0.000122	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—MAPK1—melanoma	2.27e-05	0.000121	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—EGFR—melanoma	2.27e-05	0.000121	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CDKN1B—melanoma	2.25e-05	0.00012	CbGpPWpGaD
Oxymorphone—OPRM1—GPCR downstream signaling—AKT1—melanoma	2.22e-05	0.000118	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—VEGFA—melanoma	2.21e-05	0.000118	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CASP3—melanoma	2.2e-05	0.000117	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL2—melanoma	2.2e-05	0.000117	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—STAT3—melanoma	2.19e-05	0.000117	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—IL6—melanoma	2.19e-05	0.000117	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—NRAS—melanoma	2.18e-05	0.000116	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP17A1—melanoma	2.16e-05	0.000115	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—KRAS—melanoma	2.14e-05	0.000114	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CCND1—melanoma	2.14e-05	0.000114	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CTNNB1—melanoma	2.12e-05	0.000113	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PRKCA—melanoma	2.11e-05	0.000112	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ERCC2—melanoma	2.09e-05	0.000111	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK3—melanoma	2.09e-05	0.000111	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MMP9—melanoma	2.08e-05	0.000111	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—CDKN1A—melanoma	2.07e-05	0.000111	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PTEN—melanoma	2.07e-05	0.00011	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NFKB1—melanoma	2.06e-05	0.00011	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GNA11—melanoma	2.04e-05	0.000109	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MYC—melanoma	2.03e-05	0.000108	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling by GPCR—AKT1—melanoma	2.02e-05	0.000108	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—FASN—melanoma	2e-05	0.000106	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—MAPK1—melanoma	1.99e-05	0.000106	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—EGFR—melanoma	1.99e-05	0.000106	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—PIK3CA—melanoma	1.97e-05	0.000105	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—SLC5A5—melanoma	1.96e-05	0.000105	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—TP53—melanoma	1.9e-05	0.000102	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—GNAQ—melanoma	1.9e-05	0.000101	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CD44—melanoma	1.9e-05	0.000101	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—KRAS—melanoma	1.88e-05	0.0001	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—VEGFA—melanoma	1.87e-05	9.96e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—STAT3—melanoma	1.85e-05	9.86e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—NRAS—melanoma	1.84e-05	9.84e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—HRAS—melanoma	1.82e-05	9.71e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—CYP1B1—melanoma	1.82e-05	9.7e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK3—melanoma	1.77e-05	9.42e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—IL6—melanoma	1.74e-05	9.3e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—PIK3CA—melanoma	1.73e-05	9.21e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MYC—melanoma	1.72e-05	9.16e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—MAPK1—melanoma	1.68e-05	8.97e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—EGFR—melanoma	1.68e-05	8.96e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—TP53—melanoma	1.67e-05	8.91e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CG—melanoma	1.65e-05	8.81e-05	CbGpPWpGaD
Oxymorphone—OPRD1—Signaling Pathways—AKT1—melanoma	1.61e-05	8.58e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—HRAS—melanoma	1.6e-05	8.52e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PPARG—melanoma	1.59e-05	8.5e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—KRAS—melanoma	1.59e-05	8.47e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—IL6—melanoma	1.53e-05	8.15e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ABCB1—melanoma	1.5e-05	7.99e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—PIK3CA—melanoma	1.46e-05	7.78e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CD—melanoma	1.45e-05	7.74e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—ALB—melanoma	1.43e-05	7.64e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—TP53—melanoma	1.41e-05	7.53e-05	CbGpPWpGaD
Oxymorphone—OPRK1—Signaling Pathways—AKT1—melanoma	1.41e-05	7.52e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PRKCA—melanoma	1.38e-05	7.35e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ERCC2—melanoma	1.37e-05	7.29e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—HRAS—melanoma	1.35e-05	7.2e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—IL6—melanoma	1.29e-05	6.89e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CB—melanoma	1.26e-05	6.75e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTGS2—melanoma	1.25e-05	6.69e-05	CbGpPWpGaD
Oxymorphone—OPRM1—Signaling Pathways—AKT1—melanoma	1.19e-05	6.36e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PTEN—melanoma	1.09e-05	5.83e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CG—melanoma	1.08e-05	5.76e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PPARG—melanoma	1.04e-05	5.56e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CD—melanoma	9.49e-06	5.06e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—ALB—melanoma	9.37e-06	5e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CB—melanoma	8.27e-06	4.41e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTGS2—melanoma	8.19e-06	4.37e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—PIK3CA—melanoma	7.71e-06	4.11e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PTEN—melanoma	7.15e-06	3.81e-05	CbGpPWpGaD
Oxymorphone—CYP2D6—Metabolism—AKT1—melanoma	6.3e-06	3.36e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—PIK3CA—melanoma	5.04e-06	2.69e-05	CbGpPWpGaD
Oxymorphone—CYP3A4—Metabolism—AKT1—melanoma	4.12e-06	2.2e-05	CbGpPWpGaD
